Clinerion Introduces New Services for Market Access

Clinerion announces new services for market access which give pharmaceutical companies insight into patient populations based on its health data analytics tools.

Clinerion’s Patient Recruitment System (PRS) Patient Finder tool has a wealth of health data which can now be harnessed to guide pharmaceutical companies in their R&D and commercial decision making by providing information on the prevalence of target diseases and the distribution of patient populations.

Market access is becoming an integral part of not only the commercial activities of a pharmaceutical company, but of the whole value chain, including the R&D process. As the market further matures and competition for patients increases, having a registered drug on the market is no longer a measure of success, but only an intermediate step towards success on the market. The availability of solid data to back up decision making becomes vital in ensuring the commercial future of a drug, and having real-time data becomes indispensable to market access experts.

Fully anonymized, aggregated data, sourced from the expanding network of hospitals covered by Clinerion’s PRS, can provide answers to a number of questions. Disease prevalence can be monitored with a precision never before possible, with daily updates on new cases. The financial analysis of the cost of treatments can be performed based on real data, rather than empirical interviews with physicians.

“As we venture into healthcare data analytics, we see a growing demand from pharma companies”, says Tigran Arzumanov, Head of Sales of Clinerion. “With the expansion of our global footprint, we find ourselves in geographies previously not covered by any data collection platforms. There is no substitute for data as far as market access decisions are concerned – and our technology provides a straightforward, easy way to tap into electronic health record (EHR) data globally, regardless of the EHR platform or coding conventions used.”

About Clinerion
Clinerion enables early patient access to innovative treatments through solutions for clinical trial patient recruitment, real-world evidence, and market access. Clinerion’s Patient Recruitment System accelerates clinical research by radically improving the efficiency and effectiveness of trial recruitment. Key tools for Clinerion’s patient data services include data-assisted protocol optimization, site feasibility evaluation and patient identification. Clinerion’s solutions allow member hospitals to participate in leading-edge, industry-sponsored trials and save time in patient recruitment. They enable pharmaceutical companies to gain time and cost savings by streamlining operations and gaining strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which remain under the full control of participating hospitals. Clinerion is a global data technology company headquartered in Switzerland. Clinerion’s solutions follow international patient privacy and data security standards.Clinerion website: www.clinerion.com

Clinerion’s Patient Recruitment System: www.clinerion.com/index/OverviewOurSolutions/PatientRecruitmentSystem

For more information, please contact:

Le Vin Chin
Head of Marketing and Communications
Clinerion Ltd
Margarethenstrasse 47, CH-4053 Basel, Switzerland
Tel.: +41 61 865 60 54
media@clinerion.com

Seo wordpress plugin by www.seowizard.org.